TNF Other Current Assets vs Long Term Debt Analysis
| TNFA Stock | 1.36 0.11 7.48% |
TNF Pharmaceuticals, financial indicator trend analysis is much more than just breaking down TNF Pharmaceuticals, prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TNF Pharmaceuticals, is a good investment. Please check the relationship between TNF Pharmaceuticals, Other Current Assets and its Long Term Debt accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TNF Pharmaceuticals,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.
Other Current Assets vs Long Term Debt
Other Current Assets vs Long Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TNF Pharmaceuticals, Other Current Assets account and Long Term Debt. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between TNF Pharmaceuticals,'s Other Current Assets and Long Term Debt is -0.54. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of TNF Pharmaceuticals,, assuming nothing else is changed. The correlation between historical values of TNF Pharmaceuticals,'s Other Current Assets and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of TNF Pharmaceuticals, are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Other Current Assets i.e., TNF Pharmaceuticals,'s Other Current Assets and Long Term Debt go up and down completely randomly.
Correlation Coefficient | -0.54 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Long Term Debt
Long-term debt is a debt that TNF Pharmaceuticals, has held for over one year. Long-term debt appears on TNF Pharmaceuticals, balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on TNF Pharmaceuticals, balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.Most indicators from TNF Pharmaceuticals,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TNF Pharmaceuticals, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TNF Pharmaceuticals,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.At present, TNF Pharmaceuticals,'s Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 15.4 M, whereas Enterprise Value Over EBITDA is forecasted to decline to (0.07).
| 2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 18.3K | 15.3M | 13.1M | 7.8M | Interest Income | 8.9K | 84.0K | 455.6K | 478.3K |
TNF Pharmaceuticals, fundamental ratios Correlations
Click cells to compare fundamentals
TNF Pharmaceuticals, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TNF Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TNF Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tnf Pharmaceuticals, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tnf Pharmaceuticals, Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TNF Pharmaceuticals,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TNF Pharmaceuticals,. If investors know TNF will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TNF Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.48) | Return On Assets (0.32) | Return On Equity (2.98) |
The market value of TNF Pharmaceuticals, is measured differently than its book value, which is the value of TNF that is recorded on the company's balance sheet. Investors also form their own opinion of TNF Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is TNF Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TNF Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect TNF Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TNF Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if TNF Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TNF Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.